Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency Overview

Save information for later
Sign Up

Learn About Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency

What is the definition of Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency?

Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is a condition that prevents the body from converting certain fats into energy, particularly during periods without food (fasting).

What are the causes of Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency?

Variants (also called mutations) in the ACADVL gene cause VLCAD deficiency. This gene provides instructions for making an enzyme called very long-chain acyl-CoA dehydrogenase, which is required to break down (metabolize) a group of fats called very long-chain fatty acids. These fatty acids are found in foods and the body's fat tissues. Fatty acids are a major source of energy for the heart and muscles. During periods of fasting, fatty acids are also an important energy source for the liver and other tissues.

How prevalent is Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency?

VLCAD deficiency is estimated to affect 1 in 40,000 to 120,000 people.

Is Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency an inherited disorder?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell must have a variant to cause the disorder. The parents of an individual with an autosomal recessive condition each carry one copy of the altered gene, but they typically do not show signs and symptoms of the condition.

Who are the top Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency Local Doctors?
Elite in Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency
Elite in Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency
Freiburg, BW, DE 

Sara Tucci practices in Freiburg, Germany. Ms. Tucci is rated as an Elite expert by MediFind in the treatment of Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency. Her top areas of expertise are Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency, Carnitine Palmitoyltransferase 2 Deficiency, Carnitine Palmitoyltransferase 1 Deficiency, and Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency.

Elite in Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency
Elite in Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency
Himebara, JP 

Kenji Yamada practices in Himebara, Japan. Mr. Yamada is rated as an Elite expert by MediFind in the treatment of Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency. His top areas of expertise are Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency, Glutaric Acidemia Type 2, Carnitine Palmitoyltransferase 2 Deficiency, and Rhabdomyolysis.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency
Pediatric Cardiology | Pediatrics
Experienced in Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency
Pediatric Cardiology | Pediatrics

University Hospitals Medical Group Inc

11100 Euclid Ave, 
Cleveland, OH 
Languages Spoken:
English
Accepting New Patients

James Strainic is a Pediatric Cardiologist and a Pediatrics provider in Cleveland, Ohio. Dr. Strainic is rated as an Experienced provider by MediFind in the treatment of Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency. His top areas of expertise are Pulmonary Atresia, Pulmonary Atresia with Intact Ventricular Septum, Ventricular Septal Defects, and Congenital Coronary Artery Malformation. Dr. Strainic is currently accepting new patients.

What are the latest Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: June 26, 2023
Published By: National Institutes of Health